Docetaxel (D), Gemcitabine (G) and Bevacizumab (BEV) as Salvage Chemotherapy (CT) for HER-2 Negative Metastatic Breast Cancer (MBC)
Kontopodis, E., Christophylakis, C., Kentepozidis, N., Boukovinas, I., Giassas, S., Saloustros, E., Kalykaki, A., Bozionelou, V., Georgoulias, V., Mavroudis, D.Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)32961-6
Date:
September, 2012
File:
PDF, 73 KB
2012